Lipid phenotypes at the extremes of high-density lipoprotein cholesterol: The very large database of lipids-9
- PMID: 26228668
- DOI: 10.1016/j.jacl.2015.05.005
Lipid phenotypes at the extremes of high-density lipoprotein cholesterol: The very large database of lipids-9
Abstract
Background: Low serum levels of high-density lipoprotein cholesterol (HDL-C) are an important risk factor for atherosclerotic disease. To date, therapeutically raising HDL-C has not been shown to impact risk for cardiovascular events.
Objective: We aim to characterize lipid parameters at the extremes of HDL-C.
Methods: We examined cholesterol profiles from 1,350,908 US adults and children from the Very Large Database of Lipids who were clinically referred for advanced lipoprotein testing from 2009 to 2011. We categorized patients into HDL-C percentile categories (<0.1th, 0.1th-<1st, 1st-5th, 25th-75th, 95th-99th, >99th-99.9th, and >99.9th). Within these groups, we examined HDL-C subclasses, low-density lipoprotein cholesterol (LDL-C), LDL and very-low density lipoprotein densities, non-HDL-C, triglycerides (TG), very-low density lipoprotein cholesterol, and remnant lipoprotein cholesterol (RLP-C), as well as prevalence of Fredrickson-Levy dyslipidemias.
Results: Extremely low HDL-C percentiles were associated with increased LDL density, TG, and especially RLP-C. Very high HDL-C levels (≥ 92 mg/dL) showed increasing HDL2-C/HDL3-C ratio and very low levels of RLP-C and triglyceride-rich lipoproteins. Type IV dyslipidemia had the highest prevalence among classical dyslipidemia and was the most frequent at extremely low HDL-C percentiles.
Conclusions: These findings demonstrate a high prevalence of elevated triglyceride-rich lipoprotein levels and increased LDL density in patients with extremely low HDL-C levels. The relative contributions of these various changes in lipid profiles of patients with low HDL-C to cardiovascular risk need to be further scrutinized to more fully establish if low HDL-C is truly an independent risk factor for coronary heart disease or simply reflects detrimental shifts in the levels of atherogenic lipoproteins.
Keywords: Cardiovascular diseases; Dyslipidemia; High-density lipoprotein cholesterol; Lipids; Prevention.
Copyright © 2015 National Lipid Association. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor? New Insights From the Framingham Offspring Study.Circ Cardiovasc Qual Outcomes. 2016 May;9(3):206-212. doi: 10.1161/CIRCOUTCOMES.115.002436. Epub 2016 May 10. Circ Cardiovasc Qual Outcomes. 2016. PMID: 27166203 Free PMC article.
-
Relationship of the triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio to the remainder of the lipid profile: The Very Large Database of Lipids-4 (VLDL-4) study.Atherosclerosis. 2015 Sep;242(1):243-50. doi: 10.1016/j.atherosclerosis.2015.06.057. Epub 2015 Jul 7. Atherosclerosis. 2015. PMID: 26232164
-
Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.J Clin Lipidol. 2015 Jul-Aug;9(4):525-32. doi: 10.1016/j.jacl.2015.05.003. Epub 2015 May 16. J Clin Lipidol. 2015. PMID: 26228670
-
Pitavastatin: novel effects on lipid parameters.Atheroscler Suppl. 2011 Nov;12(3):277-84. doi: 10.1016/S1567-5688(11)70887-X. Atheroscler Suppl. 2011. PMID: 22152282 Review.
-
Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.J Manag Care Pharm. 2008 Oct;14(8 Suppl):S3-28; quiz S30-1. J Manag Care Pharm. 2008. PMID: 19891279 Review.
Cited by
-
Characterization of lipoprotein profiles in patients with hypertriglyceridemic Fredrickson-Levy and Lees dyslipidemia phenotypes: the Very Large Database of Lipids Studies 6 and 7.Arch Med Sci. 2019 Sep;15(5):1195-1202. doi: 10.5114/aoms.2019.87207. Epub 2019 Aug 22. Arch Med Sci. 2019. PMID: 31572464 Free PMC article.
-
Effects of weight change on apolipoprotein B-containing emerging atherosclerotic cardiovascular disease (ASCVD) risk factors.Lipids Health Dis. 2019 Jul 17;18(1):154. doi: 10.1186/s12944-019-1094-4. Lipids Health Dis. 2019. PMID: 31311555 Free PMC article.
-
Associations between cardiovascular disease, cancer, and very low high-density lipoprotein cholesterol in the REasons for Geographical and Racial Differences in Stroke (REGARDS) study.Cardiovasc Res. 2019 Jan 1;115(1):204-212. doi: 10.1093/cvr/cvy198. Cardiovasc Res. 2019. PMID: 30576432 Free PMC article.
-
Impact of variants in CETP and apo AI genes on serum HDL cholesterol levels in men and women from the Polish population.Arch Med Sci. 2016 Dec 1;12(6):1188-1198. doi: 10.5114/aoms.2016.60870. Epub 2016 Jun 27. Arch Med Sci. 2016. PMID: 27904507 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous